The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially inflating costs over the years. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Market Domination to break down the details of the story and why the price of insulin has risen so much.

For more expert insight and the latest market action, click here to watch this full episode of Market Domination.

This post was written by Melanie Riehl